Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor

Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor

US Patent 8067375 · Granted Nov 29, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and treatments using toll-like receptor agonists to mitigate hematopoiet2024
Methods and compositions for inducing an immune response2021
Methods of modulating immune responses using BCMA polypeptide2019
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)2017
Methods and compositions for the treatment of immune disorders2014
Methods of screening for a compound that inhibits the interaction between BAFF a2014
Method for increasing expression of active tumor necrosis factor receptor family2014
Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated d2013
Compositions comprising variant LT-B-R-IG fusion proteins2012
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand anti2012
Method for the high level expression of active tumor necrosis receptor family me2012
Treatment of follicular lymphomas using inhibitors of the LT pathway2012